Phase 2 RCT in 34 malaria-experienced Malian adults: ProC6C-AlOH/Matrix-M vs rabies vaccine gave 76% efficacy against P falciparum infection after controlled challenge (6/16 vs 13/16 infected); adverse events 76% vs 18%, mostly mild.
RCTn = 34
Kone et al. Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study